Sort
34,240 grants matching “atherosclerosis”
Mechanisms of Lipid Droplet Protein Targeting
$403,750Tobias C Walther · Harvard School Of Public Health · R01 · FY2014 · GM
Effects of PC remodeling on macrophages and adipocytes: its relevance to atherosclerosis
$403,750Xian-Cheng Jiang · Suny Downstate Medical Center · R01 · FY2018 · HL
The role of fatty acid binding protein aP2 in the pathogenesis and treatment of asthma
$403,750Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2016 · AI
Somatic TET2 mutation-driven clonal hematopoiesis in atherosclerosis
$403,750Coleen A McNamara · University Of Virginia · R01 · FY2020 · HL
Elucidating a role for Calcium signaling in activation of the Nlrp3 inflammasome
$403,750Tiffany Horng · Harvard School Of Public Health · R01 · FY2017 · AI
Effects of PC remodeling on macrophages and adipocytes: its relevance to atherosclerosis
$403,750Xian-Cheng Jiang · Suny Downstate Medical Center · R01 · FY2020 · HL
Inflammation and Infection in Atherosclerosis
$403,750Boston University Medical Campus · R01 · FY2005 · HL
Elucidating a role for Calcium signaling in activation of the Nlrp3 inflammasome
$403,750Tiffany Horng · Harvard School Of Public Health · R01 · FY2015 · AI
Somatic TET2 mutation-driven clonal hematopoiesis in atherosclerosis
$403,750Coleen A McNamara · University Of Virginia · R01 · FY2022 · HL
Role of Foxa2 in ligand-dependent activation of nuclear receptors
$403,750Irina Bochkis · University Of Virginia · R01 · FY2022 · DK
Pannexin 1 channels in diet-induced metabolic syndrome
$403,750Norbert Leitinger · University Of Virginia · P01 · FY2019 · HL
The role of immunometabolic pathways in atherosclerosis
$403,750Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2015 · HL
Role of Foxa2 in ligand-dependent activation of nuclear receptors
$403,750Irina Bochkis · University Of Virginia · R01 · FY2021 · DK
Effects of PC remodeling on macrophages and adipocytes: its relevance to atherosclerosis
$403,750Xian-Cheng Jiang · Suny Downstate Medical Center · R01 · FY2019 · HL
Somatic TET2 mutation-driven clonal hematopoiesis in atherosclerosis
$403,750Coleen A McNamara · University Of Virginia · R01 · FY2019 · HL
REGULATION OF VESSEL WALL APOPTOSIS
$403,750Boston University Medical Campus · R37 · FY2003 · AG
The role of immunometabolic pathways in atherosclerosis
$403,750Gokhan S Hotamisligil · Harvard School Of Public Health · R01 · FY2017 · HL
Hypochlorite-Mediated Impairment of Endothelial Function
$403,750Boston University Medical Campus · R01 · FY2005 · HL
BAFF 60mer as a novel therapeutic target for vascular diseases
$403,750Akshaya Kumar Meher · University Of Virginia · R01 · FY2019 · HL
Protecting the Cerebrovasculature during Hypertension: Role of PPARy in Smooth Mu
$403,697Frank M Faraci · University Of Iowa · P01 · FY2013 · HL
GENE THERAPY FOR DYSLIPIDEMIA AND ATHEROSCLEROSIS
$403,669University Of Pennsylvania · P01 · FY2004 · HL
Carotid Intima-Media Thickness in Chronic Kidney Disease: a CRIC ancillary study
$403,652Sylvia E Rosas · University Of Pennsylvania · R01 · FY2011 · DK
The role of CDKN2B in efferocytosis and atherosclerosis
$403,644Nicholas James Leeper · Stanford University · R01 · FY2015 · HL
The role of CDKN2B in efferocytosis and atherosclerosis
$403,644Nicholas James Leeper · Stanford University · R01 · FY2017 · HL
The role of CDKN2B in efferocytosis and atherosclerosis
$403,644Nicholas James Leeper · Stanford University · R01 · FY2016 · HL